Ad for Breast Cancer Drug Cited for False Promises

Published on January 22, 2024

A happy child runs up the steps of a house, where her grandmother, glowing with health and a smile, plays a card game with the child’s sister. Grandpa relaxes on the porch before coming down to join the game. The family is happy and carefree. “Postmenopausal women with HR-positive HER-2 negative metastatic breast cancer are living longer with Kisqali,” the voiceover begins as the happy family continues to play. Pharmaceutical company Novartis is in hot water with the U.S. Food and Drug Administration (FDA) for making false and misleading representations about the efficacy of Kisqali, a drug prescribed to treat women with breast cancer, in an advertisement....

Continue reading on website
Other news

US, Allies Target Suspected Hamas Financial Networks and Iran-Linked Actors With New Sanctions

January 22, 2024
The U.S. Treasury Department has applied new sanctions targeting an Iraqi airline and multiple Middle Eastern groups with suspected ties to the Iran’s Islamic regime.The Treasury Department’s Office of Foreign Assets Control (OFAC) designated the Iraqi airline operator Fly Baghdad for sanctions, alleging the airline operator and its CEO, Basheer Abdulkadhim Alwan al-Shabbani, have provided assista

Major Recession Signal Flashes Red Amid ‘Soft Landing’ Talk

January 22, 2024
A top recession indicator is flashing red for the 21st consecutive month, signaling a downturn on the horizon. But a chorus of economists has championed a soft landing, with many experts expecting the U.S. economy to avert back-to-back quarters of negative growth.The Conference Board’s Leading Economic Index (LEI), a gauge of the economy’s strength, slipped 0.1 percent in December, up from the 0.5